13F filing recap · Q1 2010

What did ValueAct Capital buy in Q1 2010?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.83B

Positions

Estimated turnover

16.1%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

MYGNMyriad Genetics, Inc.$14.96Mreported value+622.0K shares ESEnergysolutions Inc$6.53Mreported value+1.01M shares

Increased positions

BCRC.r. Bard, Inc.$233.94Mreported value+66.2K shares+2.5%VRSNVeriSign Inc/ca$188.65Mreported value+3.60M shares+98.9%IU1Immucor Inc$109.33Mreported value+425.0K shares+9.5%SNASnap-On Inc$75.80Mreported value+568.4K shares

Reduced positions

MDZMds Inc$78.94Mreported value-13.37M shares-57.9%BFHBread Financial Holdings, Inc.$32.00Mreported value-2.08M shares-80.6%WCRXWarner Chilcott Plc$10.21Mreported value-1.33M shares-76.8%